141 related articles for article (PubMed ID: 26241398)
21. Highly effective biosynthesis of N-acetylated human thymosin β4 (Tβ4) in Escherichia coli.
Yu R; Cao S; Liu Y; Si X; Fang T; Sun X; Dai H; Xu J; Fang H; Chen W
Artif Cells Nanomed Biotechnol; 2018; 46(sup3):S95-S104. PubMed ID: 29989423
[TBL] [Abstract][Full Text] [Related]
22. Beneficial effects of thymosin β4 on spinal cord injury in the rat.
Cheng P; Kuang F; Zhang H; Ju G; Wang J
Neuropharmacology; 2014 Oct; 85():408-16. PubMed ID: 24937047
[TBL] [Abstract][Full Text] [Related]
23. Thymosin beta4: structure, function, and biological properties supporting current and future clinical applications.
Crockford D; Turjman N; Allan C; Angel J
Ann N Y Acad Sci; 2010 Apr; 1194():179-89. PubMed ID: 20536467
[TBL] [Abstract][Full Text] [Related]
24. Thymosin β4 limits inflammation through autophagy.
Renga G; Oikonomou V; Stincardini C; Pariano M; Borghi M; Costantini C; Bartoli A; Garaci E; Goldstein AL; Romani L
Expert Opin Biol Ther; 2018 Jul; 18(sup1):171-175. PubMed ID: 30063848
[TBL] [Abstract][Full Text] [Related]
25. Identification and quantification of thymosin beta4 in human saliva and tears.
Badamchian M; Damavandy AA; Damavandy H; Wadhwa SD; Katz B; Goldstein AL
Ann N Y Acad Sci; 2007 Sep; 1112():458-65. PubMed ID: 17600285
[TBL] [Abstract][Full Text] [Related]
26. Progression of ocular sulfur mustard injury: development of a model system.
Milhorn D; Hamilton T; Nelson M; McNutt P
Ann N Y Acad Sci; 2010 Apr; 1194():72-80. PubMed ID: 20536452
[TBL] [Abstract][Full Text] [Related]
27. LASIK and dry eye.
Toda I
Compr Ophthalmol Update; 2007; 8(2):79-85; discussion 87-9. PubMed ID: 17540125
[TBL] [Abstract][Full Text] [Related]
28. [Research advances on thymosin β4 in promoting wound healing].
Gao YX; Wang LF; Ba SJ; Cao JL; Li F; Li B; Zhou B
Zhonghua Shao Shang Yu Chuang Mian Xiu Fu Za Zhi; 2022 Apr; 38(4):378-384. PubMed ID: 35462518
[TBL] [Abstract][Full Text] [Related]
29. Thymosin beta4 accelerates wound healing.
Malinda KM; Sidhu GS; Mani H; Banaudha K; Maheshwari RK; Goldstein AL; Kleinman HK
J Invest Dermatol; 1999 Sep; 113(3):364-8. PubMed ID: 10469335
[TBL] [Abstract][Full Text] [Related]
30. Thymosin β4: Roles in Development, Repair, and Engineering of the Cardiovascular System.
Marks ED; Kumar A
Vitam Horm; 2016; 102():227-49. PubMed ID: 27450737
[TBL] [Abstract][Full Text] [Related]
31. [Expression of laminin 5 in rat skin wounds regulated by recombinant thymosin beta4].
Li Y; Wang G; Yu H; Yang X; Xu S; Nie L; Che Y
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2008 Nov; 22(11):1306-10. PubMed ID: 19068595
[TBL] [Abstract][Full Text] [Related]
32. Management of dysfunctional tear syndrome: a Canadian consensus.
Jackson WB
Can J Ophthalmol; 2009 Aug; 44(4):385-94. PubMed ID: 19606158
[TBL] [Abstract][Full Text] [Related]
33. Comparison of topical cyclosporine, punctal occlusion, and a combination for the treatment of dry eye.
Roberts CW; Carniglia PE; Brazzo BG
Cornea; 2007 Aug; 26(7):805-9. PubMed ID: 17667613
[TBL] [Abstract][Full Text] [Related]
34. Antiinflammatory therapy for dry eye.
Pflugfelder SC
Am J Ophthalmol; 2004 Feb; 137(2):337-42. PubMed ID: 14962426
[TBL] [Abstract][Full Text] [Related]
35. Antioxidant and inflammatory cytokine in tears of patients with dry eye syndrome treated with preservative-free versus preserved eye drops.
Jee D; Park SH; Kim MS; Kim EC
Invest Ophthalmol Vis Sci; 2014 Jul; 55(8):5081-9. PubMed ID: 24994869
[TBL] [Abstract][Full Text] [Related]
36. Postrefractive surgery dry eye.
Quinto GG; Camacho W; Behrens A
Curr Opin Ophthalmol; 2008 Jul; 19(4):335-41. PubMed ID: 18545018
[TBL] [Abstract][Full Text] [Related]
37. Thymosin β4 enhances the healing of medial collateral ligament injury in rat.
Xu B; Yang M; Li Z; Zhang Y; Jiang Z; Guan S; Jiang D
Regul Pept; 2013 Jun; 184():1-5. PubMed ID: 23523891
[TBL] [Abstract][Full Text] [Related]
38. Clinical utility of objective tests for dry eye disease: variability over time and implications for clinical trials and disease management.
Sullivan BD; Crews LA; Sönmez B; de la Paz MF; Comert E; Charoenrook V; de Araujo AL; Pepose JS; Berg MS; Kosheleff VP; Lemp MA
Cornea; 2012 Sep; 31(9):1000-8. PubMed ID: 22475641
[TBL] [Abstract][Full Text] [Related]
39. Treatment of Dry Eye Disease.
Marshall LL; Roach JM
Consult Pharm; 2016 Feb; 31(2):96-106. PubMed ID: 26842687
[TBL] [Abstract][Full Text] [Related]
40. Investigation of corneal effect of different types of artificial tears in a simulated dry eye condition using a novel porcine dry eye model (pDEM).
Choy EP; Cho P; Benzie IF; Choy CK
Cornea; 2006 Dec; 25(10):1200-4. PubMed ID: 17172898
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
